Advertisement

Therapy of Secondary T-Cell Immunodeficiencies with Biological Substances and Drugs: An Update

  • J. W. Hadden
  • E. M. Hadden

Abstract

At the first meeting of this series, Meakins and Franco [1] lamented the lack of an immunopharmacologic “silver bullet” to reverse the immunosuppression observed in patients with severe trauma and burns. They pointed out that before studies of immunomodulators can be done properly, all of the variables of care must be standardized and maximized, and they particularly emphasized the opportunity for the surgeon to act as an “immunomodulator.”

Keywords

Immune Suppression Guanosine Mono Phosphate Immune Consequence Splenic Lymphocyte Silver Bullet 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Meakins JL, Franco D (1989) Immunomodulation and the surgeon. In: Faist E, Ninnemann J, Green D (eds) Immune consequences of trauma, shock and sepsis. Springer, Berlin Heidelberg New York, p 429CrossRefGoogle Scholar
  2. 2.
    Hadden JW (1989) Therapy of secondary T-cell immunodeficiencies with biological substances and drugs. In: Faist E, Ninnemann J, Green D (eds) Immune consequences of trauma, shock and sepsis. Springer, Berlin Heidelberg New York, p 509CrossRefGoogle Scholar
  3. 3.
    Ninneman JL (1989) The immune consequences of trauma: an overview. In: Faist E, Ninnemann J, Green D (eds) Immune consequences of trauma, shock and sepsis. Springer, Berlin Heidelberg New York, p 1Google Scholar
  4. 4.
    Olszewski WL, Grzelak I (1989) Trauma: immune deficiency, immune suppression, or just immune cell redistribution? In: Faist E, Ninnemann J, Green D (eds) Immune consequences of trauma, shock and sepsis. Springer, Berlin Heidelberg New York, p 9CrossRefGoogle Scholar
  5. 5.
    Faist E, Ertel W, Mewes A, Alkan S, Walz A, Strasser T (1989) Trauma-induced alterations of the lymphokine cascade. In: Faist E, Ninnemann J, Green D (eds) Immune consequences of trauma, shock and sepsis. Springer, Berlin Heidelberg New York, p 78CrossRefGoogle Scholar
  6. 6.
    Siegal JN, Schwartz A, Askenase PW, Gershon RK (1982) T-cell suppression and contra-suppression induced by histamine H2 and H1 receptor agonists, respectively. Proc Natl Acad Sci USA 79:5053CrossRefGoogle Scholar
  7. 7.
    Ozkan AN (1989) Serum mediators and the generation of immune suppression. In: Faist E, Ninneman J, Green D (eds) Immune consequences of trauma, shock and sepsis. Springer, Berlin Heidelberg New York, p 285CrossRefGoogle Scholar
  8. 8.
    Green DR, Marcotte R, Wang N (1989) The role of inhibitory cells in burn trauma-associated immunodeficiency. In: Faist E, Ninnemann J, Green D (eds) Immune consequences of trauma, shock and sepsis. Springer, Berlin Heidelberg New York, p 55CrossRefGoogle Scholar
  9. 9.
    Bolla K, Cappel R, Duchateau J, Faist E (1989) Immunomodulation as a potential therapeutic approach in immunodeficiencies. In: Faist E, Ninnemann J, Green D (eds) Immune consequences of trauma, shock and sepsis. Springer, Berlin Heidelberg New York, p 519CrossRefGoogle Scholar
  10. 10.
    Faist E (1989) Perioperative immunomodulation in patients with major surgical trauma. In: Faist E, Ninnemann J, Green D (eds) Immune consequences of trauma, shock and sepsis. Springer, Berlin Heidelberg New York, p 530CrossRefGoogle Scholar
  11. 11.
    Berd D, Maguire HC, Mastrangelo (1984) Potentiation of human cell-mediated and humoral immunity by low-dose cyclophosphamide. Cancer Res 44:5439PubMedGoogle Scholar
  12. 12.
    Winchurch RA, Xiao G-X, Munster AM, Adler WH, White C, Bender B (1989) Treatment of burn patients with polymyxin B: effects on lymphokine regulation. In: Faist E, Ninneman J, Green D (eds) Immune consequences of trauma, shock and sepsis. Springer, Berlin Heidelberg New York, p 458Google Scholar
  13. 13.
    Sagawa T, Abe Y, Kimura S, Hitsumoto Y, Utsumi S (1989) Mechanisms of neutralization of endotoxin by monoclonal IgG antibodies to lipopolysaccharide. In: Faist E, Ninnemann J, Green D (eds) Immune consequences of trauma, shock and sepsis. Springer, Berlin Heidelberg New York, p 495CrossRefGoogle Scholar
  14. 14.
    Sztein MB, Serrate SA (1990) Characterization of the immunoregulatory properties of thymosin α1 on interleukin-2 production and interleukin-2 receptor expression in normal human lymphocytes. Int J Immunopharmacol 11:789CrossRefGoogle Scholar
  15. 15.
    Klempner MS, Noring R, Mier JW, Atkins MB (1990) An acquired chemotactic defect in neutrophils from patients receiving interleukin-2 immunotherapy. N Engl J Med 5:322Google Scholar
  16. 16.
    Hadden JW, Galy A, Chen H, Wang Y, Hadden E (1989) The hormonal regulation of thymus and T lymphocyte development and function. In: Hadden JW, Masek K, Nisitco G (eds) Interactions among central nervous system, neuroendocrine and immune systems. Pythagora, Rome, p 147Google Scholar
  17. 17.
    Hadden JW, Chen H, Wang Y, Galy A, Hadden E (1989) Strategies of immune reconstitution: effects of lymphokines on murine T cell development in vitro and in vivo. Life Sci 44:vPubMedCrossRefGoogle Scholar
  18. 18.
    Hersh EM, Abrams D, Bartlett J, Brewton G, Galpin J, Gill P, Gorter R, Gottlieb M, Jonikas JJ, Landesman S, Levine A, Marcel A, Peterson EA, Whiteside M, Zahradnik J, Negron C, Boutitie F, Caraux J, Dupuy J-M, Salmi LR (1991) A randomized double-blind, placebo-controlled multicenter study of sodium ditiocarb. JAMA (in press)Google Scholar
  19. 19.
    Singh H, Herndon DN (1989) Effect of isoprinosine on lymphocyte proliferation and natural killer cell activity following thermal injury. Immunopharmacol Immunotoxicol 11(4):631PubMedCrossRefGoogle Scholar
  20. 20.
    Mocchegiani E, Cacciatore L, Talarico M, Lingetti M, Fabris N (1990) Recovery of low thymic hormone levels in cancer patients by lysine-arginine combination. Int J Immunopharmacol 12(4):365PubMedCrossRefGoogle Scholar
  21. 21.
    Buckley AR, Montgomery DW, Kibler R, Putnum CW, Zukoski CF, Gout PW, Beer CT, Russell DH (1986) Prolactin stimulation of Ornithine decarboxylase and mitogenesis in Nb2 node lymphoma cells: the role of protein kinase C and calcium mobilization. Immunopharmacology 12:37PubMedCrossRefGoogle Scholar
  22. 22.
    Mukherjee P, Mastro AM, Hymer WC (1990) Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes. Endocrinology 126:88PubMedCrossRefGoogle Scholar
  23. 23.
    Hadden E, Malec P, Hadden J (1991) Int J Immunopharmacol (in press)Google Scholar

Copyright information

© Springer-Verlag, Berlin Heidelberg 1993

Authors and Affiliations

  • J. W. Hadden
    • 1
  • E. M. Hadden
    • 1
  1. 1.Department of Internal Medicine, Division of ImmunopharmacologyUniversity of South Florida College of MedicineTampaUSA

Personalised recommendations